HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.

Abstract
Growth factors have been implicated in pancreatic carcinogenesis. In this study we analyzed the effect of Tgfa overexpression in addition to mutant Kras(G12D) by crossing Elastase-Tgfa mice with p48(+/Cre);Kras(+/LSL-G12D) mice. We show that concomitant expression of TGFalpha and Kras(G12D) accelerates the progression of mPanIN lesions to metastatic pancreatic cancer and leads to the development of cystic papillary lesions resembling human intraductal papillary mucinous neoplasms (IPMN). Microarray data in mice revealed an IPMN signature and IPMNs expressed MUC1 and MUC5AC but not MUC2, similar to human pancreatobiliary IPMNs. Invasive ductal adenocarcinoma developed from PanINs and IPMNs, suggesting precursor lines for both lesion types in this model. In conclusion, Egfr signaling in synergy with oncogenic Kras may be a prerequisite for IPMN development and progression to pancreatic cancer.
AuthorsJens T Siveke, Henrik Einwächter, Bence Sipos, Clara Lubeseder-Martellato, Günter Klöppel, Roland M Schmid
JournalCancer cell (Cancer Cell) Vol. 12 Issue 3 Pg. 266-79 (Sep 2007) ISSN: 1535-6108 [Print] United States
PMID17785207 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Transforming Growth Factor alpha
  • Pancreatic Elastase
  • Oncogene Protein p21(ras)
Topics
  • Animals
  • Carcinoma, Pancreatic Ductal (genetics, metabolism, pathology)
  • Cell Differentiation
  • Genes, ras
  • Humans
  • Mice
  • Mice, Transgenic
  • Mutation
  • Oncogene Protein p21(ras) (genetics, metabolism)
  • Pancreatic Elastase (genetics)
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • Precancerous Conditions (genetics, metabolism, pathology)
  • Promoter Regions, Genetic
  • Signal Transduction
  • Transforming Growth Factor alpha (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: